Tapewire

Nasdaq · USD

ILMN

ILLUMINA, INC.

Export transactions ↓
Tapewire entity
3137
SEC CIK
0001110803
Parsed reports
898

Last 12 months

Inside the activity.

2 purchase rows · 112 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202502
Jan 202600
Feb 202612
Mar 202600
Apr 202600
May 2026026
Jun 2026013
Jul 202601
Aug 2026056
Sep 2026012
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 3, 2023 16:31 UTC
TOUSI SUSAN HSVP, Chief Commercial Officer
GrantPerformance Shares · Derivative 4,030 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008590 · form4.xml · derivative · entry 2

TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,030

Underlying: Common Stock · 4,030 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:31 UTC
TOUSI SUSAN HSVP, Chief Commercial Officer
GrantCommon Stock 10,074 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008590 · form4.xml · nonDerivative · entry 1

TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,022

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:28 UTC
Rollins CarissaSVP, Chief Information Officer
GrantPerformance Shares · Derivative 3,023 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008589 · form4.xml · derivative · entry 3

Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,023

Underlying: Common Stock · 3,023 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:28 UTC
Rollins CarissaSVP, Chief Information Officer
GrantPerformance Shares · Derivative 2,015 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008589 · form4.xml · derivative · entry 2

Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,015

Underlying: Common Stock · 2,015 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:28 UTC
Rollins CarissaSVP, Chief Information Officer
GrantCommon Stock 5,037 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008589 · form4.xml · nonDerivative · entry 1

Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,612

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:26 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
GrantPerformance Shares · Derivative 4,156 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008588 · form4.xml · derivative · entry 3

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,156

Underlying: Common Stock · 4,156 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:26 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
GrantPerformance Shares · Derivative 2,771 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008588 · form4.xml · derivative · entry 2

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:26 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
GrantCommon Stock 6,926 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008588 · form4.xml · nonDerivative · entry 1

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,195

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:24 UTC
Pegels Kevin CarlChief of Global Operations
GrantPerformance Shares · Derivative 3,023 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008587 · form4.xml · derivative · entry 3

Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,023

Underlying: Common Stock · 3,023 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:24 UTC
Pegels Kevin CarlChief of Global Operations
GrantPerformance Shares · Derivative 2,015 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008587 · form4.xml · derivative · entry 2

Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,015

Underlying: Common Stock · 2,015 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:24 UTC
Pegels Kevin CarlChief of Global Operations
GrantCommon Stock 5,037 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008587 · form4.xml · nonDerivative · entry 1

Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,167

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:22 UTC
Hoyt Aimee LSVP, Chief People Officer
GrantPerformance Shares · Derivative 4,156 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008584 · form4.xml · derivative · entry 4

Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,156

Underlying: Common Stock · 4,156 shares

Expires 2025-12-28

F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:22 UTC
Hoyt Aimee LSVP, Chief People Officer
GrantPerformance Shares · Derivative 2,771 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008584 · form4.xml · derivative · entry 3

Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2024-12-29

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:22 UTC
Hoyt Aimee LSVP, Chief People Officer
GrantCommon Stock 6,926 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008584 · form4.xml · nonDerivative · entry 2

Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,807

F2 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:22 UTC
Hoyt Aimee LSVP, Chief People Officer
SaleCommon Stock 3,917 $199.06 $779,737.21
Disclosure

SEC source: 0001127602-23-008584 · form4.xml · nonDerivative · entry 1

Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,881

F1 · shares: The sale was made pursuant to a 10b5-1 plan.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:19 UTC
GOSWAMI JOYDEEPSVP Chief Financial Officer
GrantPerformance Shares · Derivative 6,045 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008581 · form4.xml · derivative · entry 3

GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,045

Underlying: Common Stock · 6,045 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:19 UTC
GOSWAMI JOYDEEPSVP Chief Financial Officer
GrantPerformance Shares · Derivative 4,030 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008581 · form4.xml · derivative · entry 2

GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,030

Underlying: Common Stock · 4,030 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:19 UTC
GOSWAMI JOYDEEPSVP Chief Financial Officer
GrantCommon Stock 10,074 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008581 · form4.xml · nonDerivative · entry 1

GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,726

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:16 UTC
Frank John EdwardChief Public Affairs Officer
GrantPerformance Shares · Derivative 4,534 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008579 · form4.xml · derivative · entry 3

Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,534

Underlying: Common Stock · 4,534 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:16 UTC
Frank John EdwardChief Public Affairs Officer
GrantPerformance Shares · Derivative 3,023 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008579 · form4.xml · derivative · entry 2

Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,023

Underlying: Common Stock · 3,023 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:16 UTC
Frank John EdwardChief Public Affairs Officer
GrantCommon Stock 7,556 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008579 · form4.xml · nonDerivative · entry 1

Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,270

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:14 UTC
Febbo Phillip G.SVP Chief Medical Officer
GrantPerformance Shares · Derivative 4,534 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008575 · form4.xml · derivative · entry 3

Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,534

Underlying: Common Stock · 4,534 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:14 UTC
Febbo Phillip G.SVP Chief Medical Officer
GrantPerformance Shares · Derivative 3,023 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008575 · form4.xml · derivative · entry 2

Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,023

Underlying: Common Stock · 3,023 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:14 UTC
Febbo Phillip G.SVP Chief Medical Officer
GrantCommon Stock 7,556 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008575 · form4.xml · nonDerivative · entry 1

Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,786

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:12 UTC
Ericksen Scott DVP, Chief Accounting Officer
GrantPerformance Shares · Derivative 983 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008573 · form4.xml · derivative · entry 3

Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 983

Underlying: Common Stock · 983 shares

Expires 2025-12-28

F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:12 UTC
Ericksen Scott DVP, Chief Accounting Officer
GrantPerformance Shares · Derivative 655 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008573 · form4.xml · derivative · entry 2

Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 655

Underlying: Common Stock · 655 shares

Expires 2024-12-29

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:12 UTC
Ericksen Scott DVP, Chief Accounting Officer
GrantCommon Stock 1,637 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008573 · form4.xml · nonDerivative · entry 1

Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,950

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

F2 · balance_after: Balance includes 25 shares acquired through Employee Stock Purchase Plan.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:09 UTC
deSouza Francis ADirector · President and CEO
GrantPerformance Shares · Derivative 18,888 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008569 · form4.xml · derivative · entry 3

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,888

Underlying: Common Stock · 18,888 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:09 UTC
deSouza Francis ADirector · President and CEO
GrantPerformance Shares · Derivative 12,592 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008569 · form4.xml · derivative · entry 2

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,592

Underlying: Common Stock · 12,592 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:09 UTC
deSouza Francis ADirector · President and CEO
GrantCommon Stock 31,480 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008569 · form4.xml · nonDerivative · entry 1

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,992

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:04 UTC
Dadswell CharlesSVP & General Counsel
GrantPerformance Shares · Derivative 4,156 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008566 · form4.xml · derivative · entry 3

Dadswell Charles · CIK 0001575229 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,156

Underlying: Common Stock · 4,156 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:04 UTC
Dadswell CharlesSVP & General Counsel
GrantPerformance Shares · Derivative 2,771 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008566 · form4.xml · derivative · entry 2

Dadswell Charles · CIK 0001575229 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:04 UTC
Dadswell CharlesSVP & General Counsel
GrantCommon Stock 6,926 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008566 · form4.xml · nonDerivative · entry 1

Dadswell Charles · CIK 0001575229 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Charles Dadswell Trust

Disclosed balance after: 16,967

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:02 UTC
Aravanis AlexanderSVP, Chief Technology Officer
GrantPerformance Shares · Derivative 6,045 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008564 · form4.xml · derivative · entry 3

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,045

Underlying: Common Stock · 6,045 shares

Expires 2025-12-28

F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:02 UTC
Aravanis AlexanderSVP, Chief Technology Officer
GrantPerformance Shares · Derivative 4,030 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008564 · form4.xml · derivative · entry 2

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,030

Underlying: Common Stock · 4,030 shares

Expires 2024-12-29

F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 16:02 UTC
Aravanis AlexanderSVP, Chief Technology Officer
GrantCommon Stock 10,074 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-008564 · form4.xml · nonDerivative · entry 1

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,996

F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 23:08 UTC
Aravanis AlexanderSVP, Chief Technology Officer
SaleCommon Stock 2,320 $202.16 $469,011.20
Disclosure

SEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 4

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,922

F3 · shares: The sale was made pursuant to a 10b5-1 plan.

F5 · price: Weighted average sale price representing 2,320 shares sold ranging from $201.89 to $202.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 23:08 UTC
Aravanis AlexanderSVP, Chief Technology Officer
SaleCommon Stock 3,078 $201.42 $619,970.76
Disclosure

SEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 3

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,242

F3 · shares: The sale was made pursuant to a 10b5-1 plan.

F4 · price: Weighted average sale price representing 3,078 shares sold ranging from $200.88 to $201.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 23:08 UTC
Aravanis AlexanderSVP, Chief Technology Officer
Exercise / conversionPerformance Shares · Derivative 9,292 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006855 · form4.xml · derivative · entry 5

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,292 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020.

F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 23:08 UTC
Aravanis AlexanderSVP, Chief Technology Officer
Tax withholdingCommon Stock 3,894 $202.84 $789,858.96
Disclosure

SEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 2

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,320

Read SEC document
February 21, 2023 Filed Feb 23, 2023 23:08 UTC
Aravanis AlexanderSVP, Chief Technology Officer
Exercise / conversionCommon Stock 9,292 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 1

Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,214

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020.

F2 · balance_after: Balance includes 65 shares acquired through Employee Stock Purchase Plan.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:59 UTC
deSouza Francis ADirector · President and CEO
Exercise / conversionPerformance Shares · Derivative 23,473 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006854 · form4.xml · derivative · entry 3

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,473 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:59 UTC
deSouza Francis ADirector · President and CEO
Tax withholdingCommon Stock 10,907 $202.84 $2,212,375.88
Disclosure

SEC source: 0001127602-23-006854 · form4.xml · nonDerivative · entry 2

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,512

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:59 UTC
deSouza Francis ADirector · President and CEO
Exercise / conversionCommon Stock 23,473 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006854 · form4.xml · nonDerivative · entry 1

deSouza Francis A · CIK 0001520943 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

F2 · balance_after: Balance includes 90 shares acquired through Employee Stock Purchase Plan.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:55 UTC
TOUSI SUSAN HSVP, Chief Commercial Officer
Exercise / conversionPerformance Shares · Derivative 5,869 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006853 · form4.xml · derivative · entry 3

TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,869 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:55 UTC
TOUSI SUSAN HSVP, Chief Commercial Officer
Tax withholdingCommon Stock 2,197 $202.84 $445,639.48
Disclosure

SEC source: 0001127602-23-006853 · form4.xml · nonDerivative · entry 2

TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,948

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:55 UTC
TOUSI SUSAN HSVP, Chief Commercial Officer
Exercise / conversionCommon Stock 5,869 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006853 · form4.xml · nonDerivative · entry 1

TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:51 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
Exercise / conversionPerformance Shares · Derivative 2,789 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006849 · form4.xml · derivative · entry 3

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,789 shares

Expires 2023-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020.

F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020.

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:51 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
Tax withholdingCommon Stock 704 $202.84 $142,799.36
Disclosure

SEC source: 0001127602-23-006849 · form4.xml · nonDerivative · entry 2

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,269

Read SEC document
February 21, 2023 Filed Feb 23, 2023 22:51 UTC
Reeves Kathryne GambrellSVP, Chief Marketing Officer
Exercise / conversionCommon Stock 2,789 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-006849 · form4.xml · nonDerivative · entry 1

Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.